FDA Drug Application (021911) for BANZEL by EISAI INC

Back to FDA Applications sponsored by EISAI INC

Application Number021911
Product Number001
FormTABLET;ORAL
Dosage100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBANZEL
Active IngredientRUFINAMIDE

Active IngredientCount
List of drugs with Active Ingredient RUFINAMIDE2


Back to FDA Applications sponsored by EISAI INC